21.05.2021 • NewsKBR

KBR and Cummins Cooperate on Green Ammonia

US engineering and construction group KBR and US-based multinational Cummins, a manufacturer of engines, filtration and power generation products, have agreed a non-exclusive partnership on green ammonia.

Under the terms of a Memorandum of Understanding, KBR plans to integrate Cummins’ proton exchange membrane electrolysis technology into its own proprietary green ammonia solution, K-GreeN. The companies will also work to identify areas of deeper collaboration and specific opportunities worldwide.

“Collectively, our companies have the proprietary knowhow and expertise that will allow us to offer an integrated green ammonia solution to clients worldwide and help with achieving their corporate ESG [environmental, social and governance] initiatives,” said KBR president, technology, Doug Kelly.

Amy Davis, vice president and president of new power at Cummins, added: “We see great potential to deploy large scale electrolyzer solutions in green ammonia projects and working with KBR on an integrated solution provides value for our customers while enabling decarbonization.”

Green ammonia is seen as one of the most viable options to enable a transition from fossil fuels to renewables, KBR said. It can be used directly as a carbon-free fertilizer and as an energy carrier, for instance for transporting hydrogen, and also has potential as a climate-neutral shipping fuel.

Author: Elaine Burridge, Freelance Journalist

KBR and Cummins have agreed a non-exclusive partnership on green ammonia. KBR...
KBR and Cummins have agreed a non-exclusive partnership on green ammonia. KBR will integrate Cummins’ electrolysis technology into its own proprietary K-GreeN ammonia solution. The companies will also identify areas of deeper collaboration and specific opportunities worldwide. (c) KBR

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.